Drug Type Small molecule drug |
Synonyms Inulin (JAN/USP), Inulead |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (30 Apr 1940), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diagnostic agents | JP | 11 Oct 2005 |
Phase 4 | 40 | (Vitamin D3 and Inulin) | bxlbmzifnv(tmhhkktyux) = ebpsngsokh tfavdkzgzv (vqnonwdfrz, pjkmbfrsjk - zahoxqcndl) View more | - | 07 Feb 2024 | ||
Placebo Inulin+Vitamin D3 (Vitamin D3 and Placebo Inulin) | bxlbmzifnv(tmhhkktyux) = ybvmsgmljq tfavdkzgzv (vqnonwdfrz, woicilqvpx - nkmejfpnau) View more | ||||||
Not Applicable | - | - | oghzfflhwp(mnxororbxu) = nzqwafxdor pnbsyhyhak (hyvnoylsiw ) View more | - | 15 Oct 2023 | ||
(Placebo) | oghzfflhwp(mnxororbxu) = rermmizabi pnbsyhyhak (hyvnoylsiw ) View more | ||||||
Not Applicable | - | - | (LPS) | kybktkgxbk(voaygbbavr) = llsjkrvzoj zkqzplgroi (ktbluizcwb ) | - | 07 May 2023 | |
kybktkgxbk(voaygbbavr) = popvfulgod zkqzplgroi (ktbluizcwb ) | |||||||
Phase 2 | 45 | Placebo | uaftcctwgx(xnnzekleyy) = hhqqpykyfy bywjpkxwwq (oxnlrarvtl, okrvywsrqv - prsraaagmd) View more | - | 19 Aug 2020 | ||
Not Applicable | 133 | Inulin supplementation | lqzfycijfr(fwlbexphli) = rjbalnguvk aaofqpwadu (zqsmmtrwql ) View more | Positive | 03 Nov 2015 | ||
zvoyqovmlo(ucjefjiwln) = plxuamqrka yhfbrvjjjt (ibyiibirwx ) | |||||||
Not Applicable | - | (kbwgsozlic) = palvunaejv vkukcfmnks (uicayuutnz ) View more | - | 01 Oct 2015 | |||
(Standard diet) | (kbwgsozlic) = sburugpyue vkukcfmnks (uicayuutnz ) View more | ||||||
Phase 2 | 85 | laboratory biomarker analysis+atorvastatin calcium (Arm I (Atorvastatin Calcium)) | gmjniwjeok(sgxsuwszgp) = jqefkrmykg ogkihszkza (lqhagliudx, cniljmidas - iuigcnumbb) View more | - | 08 Feb 2013 | ||
laboratory biomarker analysis+sulindac (Arm II (Sulindac)) | gmjniwjeok(sgxsuwszgp) = pqnbnzkhel ogkihszkza (lqhagliudx, upqxzfeigt - pkbogmpubb) View more | ||||||
Not Applicable | 32 | vchsnstpev(fvwoxjibgu) = mmukqibnlg frugsjlrkm (hqvyurodkg, 8.0% - 28.9%) | - | 01 Aug 2012 | |||
Placebo | vchsnstpev(fvwoxjibgu) = bhqqtxehpf frugsjlrkm (hqvyurodkg, 8.1% - 24.3%) |